Stay updated on Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe site revision was updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded Show glossary and Hide glossary controls and updated QC-related display items to show Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing the older labels/versions.SummaryDifference0.3%

- Check39 days agoChange DetectedThe page shows a new revision tag: v3.3.4, replacing the previous v3.3.3. This indicates a small update to the page's metadata without changing the study content.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page now includes a 'Locations' section with Georgia as a listed study location, and the previous 'Georgia Locations' entry was removed; the 'HHS Vulnerability Disclosure' footer link was also removed.SummaryDifference0.2%

- Check91 days agoChange DetectedThe Publications section text was updated to indicate publications are automatically filled from PubMed, and the revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page.